Kashiwabara Kosuke, Semba Hiroshi, Fujii Shinji, Tsumura Shinsuke
a Department of Respiratory Medicine , Kumamoto Regional Medical Center , Kumamoto , Japan.
Cancer Invest. 2016 Sep 13;34(8):373-7. doi: 10.1080/07357907.2016.1212061. Epub 2016 Aug 17.
We retrospectively evaluated whether preoperative percutaneous transthoracic needle biopsy (PTNB) affected the incidence of pleural recurrence in pathological stage I lung cancer patients. Pleural recurrence occurred in pure solid nodule (PSN) cases but not in ground-glass nodule cases, as evaluated using thin-section computed tomographic imaging. When the cases were restricted to sub-pleural PSN, the incidence of recurrence tended to be higher in a PTNB group (63 patients diagnosed by PTNB) than in a non-PTNB group (86 patients diagnosed by transbronchial biopsy or intraoperative diagnosis) (25% vs. 4%, p =.050). PTNB should not be performed in patients with a sub-pleural PSN.
我们进行了回顾性评估，以确定术前经皮经胸针吸活检（PTNB）是否会影响病理I期肺癌患者的胸膜复发率。根据薄层计算机断层扫描成像评估，胸膜复发发生在纯实性结节（PSN）病例中，而磨玻璃结节病例中未发生。当病例仅限于胸膜下PSN时，PTNB组（63例经PTNB诊断）的复发率往往高于非PTNB组（86例经支气管活检或术中诊断）（25%对4%，p = 0.050）。对于胸膜下PSN患者不应进行PTNB。
